Good Morning, Traders!…👋

U.S. stock futures edged lower Tuesday, putting markets on track to give back some of Monday’s modest gains as economic growth concerns resurface.

The pullback comes after the Organization for Economic Co-operation and Development (OECD) downgraded its U.S. growth forecast, now projecting the economy will expand just 1.6% this year—down from its previous estimate of 2.2%.

Treasury yields fell as investors sought safe haven assets. The yield on the 10-year Treasury note declined 4 basis points to 4.418%.

Trade tensions, particularly with China, remain a key source of anxiety for Wall Street, adding to broader concerns over the economic outlook. Despite these pressures, major indexes managed to post modest gains on Monday: the S&P 500 rose 0.4%, the Nasdaq climbed 0.7%, and the Dow inched up 0.1%.

Earnings Watch

Earnings hit today from Dollar General $DG, NIO $NIO, and Ollie’s Bargain Outlet $OLLI before open, plus CrowdStrike $CRWD and HP Enterprise $HPE after close.

Analysts expect DG to post $1.57 EPS with retail strength, NIO to hit -$0.22 EPS with EV growth, OLLI at $0.78 EPS, CRWD to deliver $0.89 EPS with cybersecurity demand, and HPE at $0.39 EPS.

Happening Today

✓ 10:00 AM ET – Factory Orders (MoM) (Apr)

✓ 10:00 AM ET - JOLTS Job Openings (Apr)

✓ 04:30 PM ET – API Weekly Crude Oil Stock

PREMARKET SNAPSHOT 📈

U.S. equity futures edged lower this morning as investors weighed renewed trade tensions and global economic concerns. Market sentiment was dampened by the OECD's downward revision of global growth forecasts, citing escalating U.S. tariffs and weakening trade activity.

SECTOR SNAPSHOT✨

Sector performance improved across the board, with nearly all segments in the green. Energy led the charge with a 1.15% gain, followed by strong showings from information technology (+0.89%) and communication services (+0.61%). Consumer discretionary, staples, and health care posted modest advances, while financials edged slightly higher. Materials and utilities also ticked up. Industrials was the only sector to dip slightly, down 0.24%, reflecting a pause after recent gains.

PreMarket Unusual Volume Stocks

📈 NewGenIvf Group Limited ($NIVF) surged 181.40% in pre-market trading, with volume hitting 16.11M shares—an explosive 37,259.81% increase. This sharp move suggests heavy speculative interest or a major catalyst at play.

📈 Conduit Pharmaceuticals Inc. ($CDT) rose 9.14% on volume of 207.08K shares, up 321.38% from average—indicating modest momentum building in the biotech name.

📈 Shineco, Inc. ($SISI) gained 39.67%, trading 11.9M shares, a 250.69% jump in volume—potentially driven by renewed investor interest in the health and wellness space.

📈 Safe and Green Development Corporation ($SGD) climbed 9.17% with 383.26K shares traded, up 226.74%. The stock is seeing growing volume, possibly reacting to recent corporate updates.

📈 NuCana plc ($NCNA) ticked up 9.47% with volume reaching 19.55M shares—a 90.47% increase—suggesting the ADR is drawing attention ahead of the session.

Premarket Picks

Greenlane Holdings, Inc. (GNLN) experienced a 9.83% surge in its pre-market price, climbing to $0.0065. The uptick came after the company announced it had been granted continued listing status by the Nasdaq hearings panel. This is contingent upon Greenlane regaining compliance with the Nasdaq Listing Rules.

NewGenIvf Group Limited (NIVF) saw a dramatic jump of 181.97% in pre-market trading, bringing its price to $4.85. The rally followed the company’s filing of a 6-K form with the U.S. Securities and Exchange Commission (SEC), which often signals significant operational or strategic updates.

Shineco, Inc. (SISI) posted a 42.71% increase, trading at $0.61 ahead of the market open. The gain came after the company filed an 8-K form with the SEC, indicating a material event or corporate change that has likely captured investor interest.

Northern Dynasty Minerals Ltd. (NAK) rose by 26.08% to $1.45 in pre-market trading. The company announced it received a $12 million payment, the third tranche of investment under a royalty agreement originally dated July 26, 2022, and later amended.

Below is a complete list of hot stocks in pre-market today:

Top Upgrades:

1. Kymera Therapeutics, Inc. (KYMR)

Analyst Firm: B. Riley
Upgraded: Neutral to Buy
Price Target: $60
Yesterday's Close: $43.13

B. Riley raised its rating on Kymera Therapeutics from Neutral to Buy and increased its price target from $38 to $60. Analysts are optimistic about Kymera Therapeutics, a company developing drugs that use the body’s own system to eliminate disease-causing proteins. Price targets range from a low of $51.00 to a high of $97.00, with a median estimate of $60.00 and an average of $61.63.

2. UBS Group AG (UBS)

Analyst Firm: Jefferies
Upgraded: Hold to Buy
Price Target: $45.19
Yesterday's Close: $31.93

Jefferies analyst Flora Bocahut upgraded UBS from Hold to Buy and set a new price target of $45.19. UBS Group AG, known for providing financial solutions to private, institutional, and corporate clients worldwide, has analyst price targets ranging from $25.56 to $45.31. The median target sits at $37.67, with an average estimate of $36.15.

3. Block, Inc. (XYZ)

Analyst Firm: Evercore ISI
Upgraded: In Line to Outperform
Price Target: $75
Yesterday's Close: $61.76

Evercore ISI analyst Adam Frisch boosted his rating on Block from In Line to Outperform, raising the price target from $58 to $75. Block, Inc., a major player in digital commerce and financial services, has a wide range of analyst price targets—from a low of $35.00 to a high of $95.00. The median target is $67.50, while the average comes in at $66.20.

Happy investing,

Maeve Grace
Editor In Chief
Premium Stock Alerts

Important: This newsletter does not provide investment advice. The stocks mentioned should not be taken as recommendations. Your investments are solely your decisions.

Disclosure: I hold no positions in any companies mentioned, either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I have no business relationship with any company whose stock is mentioned in this article.